107 related articles for article (PubMed ID: 16808956)
21. HIV receptors and cellular tropism.
Weiss RA
IUBMB Life; 2002; 53(4-5):201-5. PubMed ID: 12120995
[TBL] [Abstract][Full Text] [Related]
22. Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymerase.
Lin G; Murphy SL; Gaulton GN; Hoxie JA
J Virol Methods; 2005 Sep; 128(1-2):135-42. PubMed ID: 15941597
[TBL] [Abstract][Full Text] [Related]
23. Real-time analysis of human immunodeficiency virus type 1 Env-mediated membrane fusion by fluorescence resonance energy transfer.
Furuta RA; Nishikawa M; Fujisawa J
Microbes Infect; 2006 Feb; 8(2):520-32. PubMed ID: 16300985
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
25. Unwelcome guests with master keys: how HIV enters cells and how it can be stopped.
Doms RW
Top HIV Med; 2004; 12(4):100-3. PubMed ID: 15516706
[TBL] [Abstract][Full Text] [Related]
26. Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection.
Kamiyama H; Yoshii H; Tanaka Y; Sato H; Yamamoto N; Kubo Y
Virology; 2009 Mar; 386(1):23-31. PubMed ID: 19178925
[TBL] [Abstract][Full Text] [Related]
27. Infection of human and non-human cells by a highly fusogenic primary CD4-independent HIV-1 isolate with a truncated envelope cytoplasmic tail.
Saha K; Yan H; Nelson JA; Zerhouni-Layachi B
Virology; 2005 Jun; 337(1):30-44. PubMed ID: 15914218
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of the env gene of two CCR5/CXCR4-independent human immunodeficiency 2 primary isolates.
Santos-Costa Q; Parreira R; Moniz-Pereira J; Azevedo-Pereira JM
J Med Virol; 2009 Nov; 81(11):1869-81. PubMed ID: 19774680
[TBL] [Abstract][Full Text] [Related]
29. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
30. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 envelope protein gp140 binding studies to human brain microvascular endothelial cells.
Mendu DR; Katinger H; Sodroski J; Kim KS
Biochem Biophys Res Commun; 2007 Nov; 363(3):466-71. PubMed ID: 17888880
[TBL] [Abstract][Full Text] [Related]
32. Sphingolipids: modulators of HIV-1 infection and pathogenesis.
Rawat SS; Johnson BT; Puri A
Biosci Rep; 2005; 25(5-6):329-43. PubMed ID: 16307380
[TBL] [Abstract][Full Text] [Related]
33. CD4/CXCR4 co-expression allows productive HIV-1 infection in canine kidney MDCK cells.
Cervantes-Acosta G; Welman M; Freund F; Cohen EA; Lemay G
Virus Res; 2006 Sep; 120(1-2):138-45. PubMed ID: 16600413
[TBL] [Abstract][Full Text] [Related]
34. Ezrin, Radixin, and Moesin (ERM) proteins function as pleiotropic regulators of human immunodeficiency virus type 1 infection.
Kubo Y; Yoshii H; Kamiyama H; Tominaga C; Tanaka Y; Sato H; Yamamoto N
Virology; 2008 May; 375(1):130-40. PubMed ID: 18295815
[TBL] [Abstract][Full Text] [Related]
35. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
[TBL] [Abstract][Full Text] [Related]
36. CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates.
Laurén A; Vincic E; Hoshino H; Thorstensson R; Fenyö EM
Retrovirology; 2007 Jul; 4():50. PubMed ID: 17645788
[TBL] [Abstract][Full Text] [Related]
37. Interclade neutralization and enhancement of human immunodeficiency virus type 1 identified by an assay using HeLa cells expressing both CD4 receptor and CXCR4/CCR5 coreceptors.
Barin F; Brunet S; Brand D; Moog C; Peyre R; Damond F; Charneau P; Barre-Sinoussi F
J Infect Dis; 2004 Jan; 189(2):322-7. PubMed ID: 14722898
[TBL] [Abstract][Full Text] [Related]
38. Characterization of HIV-2 chimeric viruses unable to use CCR5 and CXCR4 coreceptors.
Santos-Costa Q; Mansinho K; Moniz-Pereira J; Azevedo-Pereira JM
Virus Res; 2009 Jun; 142(1-2):41-50. PubMed ID: 19200444
[TBL] [Abstract][Full Text] [Related]
39. Relative concordance of human immunodeficiency virus oligomeric and monomeric envelope in CCR5 coreceptor usage.
Teeravechyan S; Suphaphiphat P; Essex M; Lee TH
Virology; 2008 Jan; 370(2):443-50. PubMed ID: 17936869
[TBL] [Abstract][Full Text] [Related]
40. Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120.
Ogert RA; Wojcik L; Buontempo C; Ba L; Buontempo P; Ralston R; Strizki J; Howe JA
Virology; 2008 Apr; 373(2):387-99. PubMed ID: 18190945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
